Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells.

Authors: Kijima, Takashi; Nakagawa, Hiroshi; Shimonosono, Masataka; Chandramouleeswaran, Prasanna M; Hara, Takeo; Sahu, Varun; Kasagi, Yuta; Kikuchi, Osamu; Tanaka, Koji; Giroux, Veronique; Muir, Amanda B; Whelan, Kelly A; Ohashi, Shinya; Naganuma, Seiji; Klein-Szanto, Andres J; Shinden, Yoshiaki; Sasaki, Ken; Omoto, Itaru; Kita, Yoshiaki; Muto, Manabu; Bass, Adam J; Diehl, J Alan; Ginsberg, Gregory G; Doki, Yuichiro; Mori, Masaki; Uchikado, Yasuto; Arigami, Takaaki; Avadhani, Narayan G; Basu, Devraj; Rustgi, Anil K; Natsugoe, Shoji

Published In Cell Mol Gastroenterol Hepatol, (2019)

Abstract: Oropharyngeal and esophageal squamous cell carcinomas, especially the latter, are a lethal disease, featuring intratumoral cancer cell heterogeneity and therapy resistance. To facilitate cancer therapy in personalized medicine, three-dimensional (3D) organoids may be useful for functional characterization of cancer cells ex vivo. We investigated the feasibility and the utility of patient-derived 3D organoids of esophageal and oropharyngeal squamous cell carcinomas.We generated 3D organoids from paired biopsies representing tumors and adjacent normal mucosa from therapy-naïve patients and cell lines. We evaluated growth and structures of 3D organoids treated with 5-fluorouracil ex vivo.Tumor-derived 3D organoids were grown successfully from 15 out of 21 patients (71.4%) and passaged with recapitulation of the histopathology of the original tumors. Successful formation of tumor-derived 3D organoids was associated significantly with poor response to presurgical neoadjuvant chemotherapy or chemoradiation therapy in informative patients (P = 0.0357, progressive and stable diseases, n = 10 vs. partial response, n = 6). The 3D organoid formation capability and 5-fluorouracil resistance were accounted for by cancer cells with high CD44 expression and autophagy, respectively. Such cancer cells were found to be enriched in patient-derived 3D organoids surviving 5-fluorouracil treatment.The single cell-based 3D organoid system may serve as a highly efficient platform to explore cancer therapeutics and therapy resistance mechanisms in conjunction with morphological and functional assays with implications for translation in personalized medicine.

PubMed ID: 30510992 Exiting the NIEHS site

MeSH Terms: Animals; Autophagy/drug effects; Biopsy; Carcinoma, Squamous Cell/pathology*; Carcinoma, Squamous Cell/therapy; Cell Line, Tumor; Chemoradiotherapy; Drug Resistance, Neoplasm*; Endoscopy; Esophageal Neoplasms/pathology*; Fluorouracil/pharmacology; Fluorouracil/therapeutic use; Humans; Hyaluronan Receptors/metabolism; Mice; Organoids/pathology*; Oropharyngeal Neoplasms/pathology*; Oropharyngeal Neoplasms/therapy

Back
to Top